(MT) ArcelorMittal - Overview
Exchange: NYSE •
Country: Luxembourg •
Currency: USD •
Type: Common Stock •
ISIN: US03938L2034
Stock: Steel, Mining, Iron Ore, Coal
Total Rating 63
Risk 77
Buy Signal -0.96
| Risk 5d forecast | |
|---|---|
| Volatility | 40.0% |
| Relative Tail Risk | -9.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.58 |
| Alpha | 60.71 |
| Character TTM | |
|---|---|
| Beta | 1.027 |
| Beta Downside | 1.510 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.83% |
| CAGR/Max DD | 1.01 |
EPS (Earnings per Share)
Revenue
Description: MT ArcelorMittal March 04, 2026
ArcelorMittal SA is an integrated steel and mining company with global operations. The company produces a range of steel products, including flat and long products, and also mines iron ore and coking coal. Steel is a foundational material for construction and manufacturing.
Its diverse product portfolio serves various industrial sectors, such as automotive, construction, and energy. The company sells through a centralized marketing organization and distributors. Integrated steel producers manage the entire production process from raw materials to finished goods, offering cost efficiencies.
ArcelorMittal operates iron ore mines across several countries, including Brazil, India, and Canada.
Further research on ValueRay can provide deeper insights into ArcelorMittals financial health and market position.
Headlines to watch out for
- Global steel demand fluctuations impact revenue
- Iron ore and coking coal prices influence production costs
- Automotive and construction industry health drives sales
- Environmental regulations increase operational expenses
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 3.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 1.48 > 1.0 |
| NWC/Revenue: 13.18% < 20% (prev 12.10%; Δ 1.08% < -1%) |
| CFO/TA 0.05 > 3% & CFO 4.81b > Net Income 3.15b |
| Net Debt (7.93b) to EBITDA (5.91b): 1.34 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (764.0m) vs 12m ago -1.04% < -2% |
| Gross Margin: 54.58% > 18% (prev 0.35%; Δ 5.42k% > 0.5%) |
| Asset Turnover: 65.59% > 50% (prev 69.86%; Δ -4.27% > 0%) |
| Interest Coverage Ratio: 13.28 > 6 (EBITDA TTM 5.91b / Interest Expense TTM 223.0m) |
Altman Z'' 5.08
| A: 0.08 (Total Current Assets 30.61b - Total Current Liabilities 22.52b) / Total Assets 97.70b |
| B: 0.51 (Retained Earnings 49.92b / Total Assets 97.70b) |
| C: 0.03 (EBIT TTM 2.96b / Avg Total Assets 93.54b) |
| D: 2.54 (Book Value of Equity 104.38b / Total Liabilities 41.17b) |
| Altman-Z'' Score: 5.08 = AAA |
Beneish M -3.76
| DSRI: 0.63 (Receivables 3.48b/5.66b, Revenue 61.35b/62.44b) |
| GMI: 0.64 (GM 54.58% / 34.82%) |
| AQI: 0.89 (AQ_t 0.27 / AQ_t-1 0.30) |
| SGI: 0.98 (Revenue 61.35b / 62.44b) |
| TATA: -0.02 (NI 3.15b - CFO 4.81b) / TA 97.70b) |
| Beneish M-Score: -3.76 (Cap -4..+1) = AAA |
What is the price of MT shares?
As of March 15, 2026, the stock is trading at USD 56.64 with a total of 1,550,952 shares traded.
Over the past week, the price has changed by -8.41%, over one month by -17.32%, over three months by +10.18% and over the past year by +67.68%.
Over the past week, the price has changed by -8.41%, over one month by -17.32%, over three months by +10.18% and over the past year by +67.68%.
Is MT a buy, sell or hold?
ArcelorMittal has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy MT.
- StrongBuy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61.4 | 8.4% |
| Analysts Target Price | 61.4 | 8.4% |
MT Fundamental Data Overview March 11, 2026
P/E Trailing = 13.5839
P/E Forward = 13.986
P/S = 0.6974
P/B = 0.7802
P/EG = 0.417
Revenue TTM = 61.35b USD
EBIT TTM = 2.96b USD
EBITDA TTM = 5.91b USD
Long Term Debt = 10.67b USD (from longTermDebt, last quarter)
Short Term Debt = 2.74b USD (from shortTermDebt, last quarter)
Debt = 13.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.93b USD (from netDebt column, last quarter)
Enterprise Value = 50.72b USD (42.79b + Debt 13.41b - CCE 5.48b)
Interest Coverage Ratio = 13.28 (Ebit TTM 2.96b / Interest Expense TTM 223.0m)
EV/FCF = 107.7x (Enterprise Value 50.72b / FCF TTM 471.0m)
FCF Yield = 0.93% (FCF TTM 471.0m / Enterprise Value 50.72b)
FCF Margin = 0.77% (FCF TTM 471.0m / Revenue TTM 61.35b)
Net Margin = 5.14% (Net Income TTM 3.15b / Revenue TTM 61.35b)
Gross Margin = 54.58% ((Revenue TTM 61.35b - Cost of Revenue TTM 27.86b) / Revenue TTM)
Gross Margin QoQ = 9.26% (prev 8.79%)
Tobins Q-Ratio = 0.52 (Enterprise Value 50.72b / Total Assets 97.70b)
Interest Expense / Debt = 0.68% (Interest Expense 91.0m / Debt 13.41b)
Taxrate = 9.97% (359.0m / 3.60b)
NOPAT = 2.67b (EBIT 2.96b * (1 - 9.97%))
Current Ratio = 1.36 (Total Current Assets 30.61b / Total Current Liabilities 22.52b)
Debt / Equity = 0.25 (Debt 13.41b / totalStockholderEquity, last quarter 54.47b)
Debt / EBITDA = 1.34 (Net Debt 7.93b / EBITDA 5.91b)
Debt / FCF = 16.85 (Net Debt 7.93b / FCF TTM 471.0m)
Total Stockholder Equity = 53.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.37% (Net Income 3.15b / Total Assets 97.70b)
RoE = 5.87% (Net Income TTM 3.15b / Total Stockholder Equity 53.66b)
RoCE = 4.60% (EBIT 2.96b / Capital Employed (Equity 53.66b + L.T.Debt 10.67b))
RoIC = 4.00% (NOPAT 2.67b / Invested Capital 66.59b)
WACC = 7.53% (E(42.79b)/V(56.20b) * Re(9.70%) + D(13.41b)/V(56.20b) * Rd(0.68%) * (1-Tc(0.10)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.43%
[DCF] Terminal Value 72.42% ; FCFF base≈471.0m ; Y1≈309.2m ; Y5≈141.1m
[DCF] Fair Price = N/A (negative equity: EV 3.01b - Net Debt 7.93b = -4.92b; debt exceeds intrinsic value)
EPS Correlation: -72.37 | EPS CAGR: -34.77% | SUE: 0.21 | # QB: 0
Revenue Correlation: -83.23 | Revenue CAGR: -9.58% | SUE: -1.13 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.45 | Chg7d=+0.117 | Chg30d=+0.197 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=5.19 | Chg7d=+0.037 | Chg30d=+0.123 | Revisions Net=+3 | Growth EPS=+34.9% | Growth Revenue=+9.5%
EPS next Year (2027-12-31): EPS=6.88 | Chg7d=+0.077 | Chg30d=+0.196 | Revisions Net=+1 | Growth EPS=+32.4% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 9.7% - Earnings Yield 7.4%)
[Growth] Growth Spread = +3.9% (Analyst 6.2% - Implied 2.3%)
P/E Forward = 13.986
P/S = 0.6974
P/B = 0.7802
P/EG = 0.417
Revenue TTM = 61.35b USD
EBIT TTM = 2.96b USD
EBITDA TTM = 5.91b USD
Long Term Debt = 10.67b USD (from longTermDebt, last quarter)
Short Term Debt = 2.74b USD (from shortTermDebt, last quarter)
Debt = 13.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.93b USD (from netDebt column, last quarter)
Enterprise Value = 50.72b USD (42.79b + Debt 13.41b - CCE 5.48b)
Interest Coverage Ratio = 13.28 (Ebit TTM 2.96b / Interest Expense TTM 223.0m)
EV/FCF = 107.7x (Enterprise Value 50.72b / FCF TTM 471.0m)
FCF Yield = 0.93% (FCF TTM 471.0m / Enterprise Value 50.72b)
FCF Margin = 0.77% (FCF TTM 471.0m / Revenue TTM 61.35b)
Net Margin = 5.14% (Net Income TTM 3.15b / Revenue TTM 61.35b)
Gross Margin = 54.58% ((Revenue TTM 61.35b - Cost of Revenue TTM 27.86b) / Revenue TTM)
Gross Margin QoQ = 9.26% (prev 8.79%)
Tobins Q-Ratio = 0.52 (Enterprise Value 50.72b / Total Assets 97.70b)
Interest Expense / Debt = 0.68% (Interest Expense 91.0m / Debt 13.41b)
Taxrate = 9.97% (359.0m / 3.60b)
NOPAT = 2.67b (EBIT 2.96b * (1 - 9.97%))
Current Ratio = 1.36 (Total Current Assets 30.61b / Total Current Liabilities 22.52b)
Debt / Equity = 0.25 (Debt 13.41b / totalStockholderEquity, last quarter 54.47b)
Debt / EBITDA = 1.34 (Net Debt 7.93b / EBITDA 5.91b)
Debt / FCF = 16.85 (Net Debt 7.93b / FCF TTM 471.0m)
Total Stockholder Equity = 53.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.37% (Net Income 3.15b / Total Assets 97.70b)
RoE = 5.87% (Net Income TTM 3.15b / Total Stockholder Equity 53.66b)
RoCE = 4.60% (EBIT 2.96b / Capital Employed (Equity 53.66b + L.T.Debt 10.67b))
RoIC = 4.00% (NOPAT 2.67b / Invested Capital 66.59b)
WACC = 7.53% (E(42.79b)/V(56.20b) * Re(9.70%) + D(13.41b)/V(56.20b) * Rd(0.68%) * (1-Tc(0.10)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.43%
[DCF] Terminal Value 72.42% ; FCFF base≈471.0m ; Y1≈309.2m ; Y5≈141.1m
[DCF] Fair Price = N/A (negative equity: EV 3.01b - Net Debt 7.93b = -4.92b; debt exceeds intrinsic value)
EPS Correlation: -72.37 | EPS CAGR: -34.77% | SUE: 0.21 | # QB: 0
Revenue Correlation: -83.23 | Revenue CAGR: -9.58% | SUE: -1.13 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.45 | Chg7d=+0.117 | Chg30d=+0.197 | Revisions Net=+1 | Analysts=3
EPS current Year (2026-12-31): EPS=5.19 | Chg7d=+0.037 | Chg30d=+0.123 | Revisions Net=+3 | Growth EPS=+34.9% | Growth Revenue=+9.5%
EPS next Year (2027-12-31): EPS=6.88 | Chg7d=+0.077 | Chg30d=+0.196 | Revisions Net=+1 | Growth EPS=+32.4% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 9.7% - Earnings Yield 7.4%)
[Growth] Growth Spread = +3.9% (Analyst 6.2% - Implied 2.3%)